This brand name is authorized in Finland
The drug DITEKIPOL contains a combination of these active pharmaceutical ingredients (APIs):
1
Clostridium tetani toxoid, adsorbed
UNII K3W1N8YP13 - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
|
|
2
Corynebacterium diphtheriae toxoid, adsorbed
UNII 3U7E3O07S8 - CORYNEBACTERIUM DIPHTHERIAE
|
|
3 Bordetella pertussis toxoid, adsorbed |
|
4
Poliovirus type 1 (Brunhilde), inactivated
UNII 0LVY784C09 - POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)
|
|
5
Poliovirus type 2 (MEF-1), inactivated
UNII 23JE9KDF4R - POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED)
|
|
6
Poliovirus type 3 (Saukett), inactivated
UNII 459ROM8M9M - POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
J07CA02 | Diphtheria-pertussis-poliomyelitis-tetanus | J Antiinfectives for systemic use → J07 Vaccines → J07C Bacterial and viral vaccines, combined → J07CA Bacterial and viral vaccines, combined |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: FI | Lรครคkealan turvallisuus- ja kehittรคmiskeskus | Identifier(s): 569913, 569921 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.